U.K. regulatory fees to rise
This article was originally published in The Gray Sheet
Executive Summary
U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) proposes to raise fees related to Notified Body and Conformity Assessment Body device regulatory activity on April 1, 2010. The move will raise overall fee income by "just over 1%" to about £351,000 from £347,000, according to the agency. Comments will be accepted until Jan. 8, 2010